Aurobindo Pharma Limited (AUROPHARMA.NS)
INR 1266.0
(1.48%)
INR 1266.0
(1.48%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 31.72 Billion INR | 64.62% |
| 2022 | 19.27 Billion INR | -27.21% |
| 2021 | 26.48 Billion INR | -50.36% |
| 2020 | 53.34 Billion INR | 87.51% |
| 2019 | 28.45 Billion INR | 20.32% |
| 2018 | 23.64 Billion INR | -2.41% |
| 2017 | 24.23 Billion INR | 5.28% |
| 2016 | 23.01 Billion INR | 16.13% |
| 2015 | 19.82 Billion INR | 25.78% |
| 2014 | 15.75 Billion INR | 34.35% |
| 2013 | 11.72 Billion INR | 299.12% |
| 2012 | 2.93 Billion INR | 337.94% |
| 2011 | -1.23 Billion INR | -121.92% |
| 2010 | 5.63 Billion INR | 0.01% |
| 2009 | 5.63 Billion INR | 461.94% |
| 2008 | 1 Billion INR | -57.96% |
| 2007 | 2.38 Billion INR | 18.67% |
| 2006 | 2 Billion INR | 188.32% |
| 2005 | 697 Million INR | 2044.62% |
| 2004 | 32.5 Million INR | -97.01% |
| 2003 | 1.08 Billion INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 9.19 Billion INR | 1.15% |
| 2023 Q2 | 7.57 Billion INR | 32.66% |
| 2023 Q3 | 9.36 Billion INR | 23.65% |
| 2023 Q4 | 9.08 Billion INR | -2.94% |
| 2023 FY | 31.72 Billion INR | 64.62% |
| 2023 Q1 | 5.7 Billion INR | 12.74% |
| 2022 FY | 19.27 Billion INR | -27.21% |
| 2022 Q2 | 4.09 Billion INR | -21.34% |
| 2022 Q1 | 5.2 Billion INR | -9.7% |
| 2022 Q3 | 4.91 Billion INR | 19.98% |
| 2022 Q4 | 5.06 Billion INR | 3.06% |
| 2021 Q2 | 6.96 Billion INR | -9.48% |
| 2021 Q3 | 6.04 Billion INR | -13.24% |
| 2021 Q4 | 5.76 Billion INR | -4.67% |
| 2021 Q1 | 7.69 Billion INR | -3.94% |
| 2021 FY | 26.48 Billion INR | -50.36% |
| 2020 Q2 | 8.07 Billion INR | 3.16% |
| 2020 Q3 | 29.48 Billion INR | 264.94% |
| 2020 FY | 53.34 Billion INR | 87.51% |
| 2020 Q4 | 8.01 Billion INR | -72.81% |
| 2020 Q1 | 7.83 Billion INR | -7.86% |
| 2019 Q1 | 6.35 Billion INR | 8.61% |
| 2019 FY | 28.45 Billion INR | 20.32% |
| 2019 Q4 | 8.49 Billion INR | 20.47% |
| 2019 Q3 | 7.05 Billion INR | 10.25% |
| 2019 Q2 | 6.39 Billion INR | 0.63% |
| 2018 Q1 | 4.55 Billion INR | -13.78% |
| 2018 FY | 23.64 Billion INR | -2.41% |
| 2018 Q4 | 5.85 Billion INR | -17.8% |
| 2018 Q3 | 7.12 Billion INR | 16.47% |
| 2018 Q2 | 6.11 Billion INR | 34.2% |
| 2017 Q1 | 5.18 Billion INR | -2.62% |
| 2017 FY | 24.23 Billion INR | 5.28% |
| 2017 Q4 | 5.28 Billion INR | -11.18% |
| 2017 Q3 | 5.95 Billion INR | -23.83% |
| 2017 Q2 | 7.81 Billion INR | 50.65% |
| 2016 Q3 | 5.78 Billion INR | -4.47% |
| 2016 FY | 23.01 Billion INR | 16.13% |
| 2016 Q2 | 6.05 Billion INR | 3.54% |
| 2016 Q1 | 5.84 Billion INR | 5.44% |
| 2016 Q4 | 5.32 Billion INR | -7.97% |
| 2015 Q2 | 4.53 Billion INR | -4.0% |
| 2015 Q4 | 5.54 Billion INR | 1.92% |
| 2015 Q3 | 5.44 Billion INR | 20.01% |
| 2015 Q1 | 4.72 Billion INR | 17.0% |
| 2015 FY | 19.82 Billion INR | 25.78% |
| 2014 Q1 | 4.15 Billion INR | -17.21% |
| 2014 FY | 15.75 Billion INR | 34.35% |
| 2014 Q4 | 4.03 Billion INR | 5.06% |
| 2014 Q3 | 3.84 Billion INR | 3.27% |
| 2014 Q2 | 3.72 Billion INR | -10.41% |
| 2013 FY | 11.72 Billion INR | 299.12% |
| 2013 Q4 | 5.01 Billion INR | 20.2% |
| 2013 Q1 | 186 Million INR | -82.87% |
| 2013 Q2 | 2.34 Billion INR | 1163.17% |
| 2013 Q3 | 4.17 Billion INR | 77.69% |
| 2012 FY | 2.93 Billion INR | 337.94% |
| 2012 Q4 | 1.08 Billion INR | 18.3% |
| 2012 Q3 | 918.1 Million INR | -58.71% |
| 2012 Q1 | -1.28 Billion INR | -219.36% |
| 2012 Q2 | 2.22 Billion INR | 272.48% |
| 2011 Q3 | -285.4 Million INR | 0.0% |
| 2011 Q4 | 1.08 Billion INR | 478.42% |
| 2011 FY | -1.23 Billion INR | -121.92% |
| 2010 FY | 5.63 Billion INR | 0.01% |
| 2009 FY | 5.63 Billion INR | 461.94% |
| 2008 FY | 1 Billion INR | -57.96% |
| 2007 FY | 2.38 Billion INR | 18.67% |
| 2006 FY | 2 Billion INR | 188.32% |
| 2005 FY | 697 Million INR | 2044.62% |
| 2004 FY | 32.5 Million INR | -97.01% |
| 2003 FY | 1.08 Billion INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Sigachi Industries Limited | 571.8 Million INR | -5449.071% |
| Ind-Swift Limited | 142.31 Million INR | -22195.714% |
| Bajaj HealthCare Limited | -837.93 Million INR | 3886.672% |
| Sakar Healthcare Limited | 116.7 Million INR | -27087.021% |
| Innova Captab Limited | 943.45 Million INR | -3263.157% |
| Divi's Laboratories Limited | 16 Billion INR | -98.311% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -1864.566% |
| Morepen Laboratories Limited | 961.59 Million INR | -3199.681% |
| Mankind Pharma Limited | 19.12 Billion INR | -65.873% |
| Sequent Scientific Limited | -358.69 Million INR | 8945.995% |
| Wanbury Limited | 559.56 Million INR | -5570.443% |
| Laurus Labs Limited | 1.6 Billion INR | -1876.313% |
| Nectar Lifesciences Limited | 49.95 Million INR | -63422.923% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | -573.827% |
| Alembic Limited | 2.68 Billion INR | -1081.215% |
| Hikal Limited | 696 Million INR | -4458.865% |
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | -415.243% |
| Neuland Laboratories Limited | 3 Billion INR | -957.379% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | -474.16% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 311.296% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -2260.314% |
| Themis Medicare Limited | 435.23 Million INR | -7190.195% |
| RPG Life Sciences Limited | 876.6 Million INR | -3519.633% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 17.788% |
| Lupin Limited | 19.14 Billion INR | -65.735% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -6955.34% |
| Wockhardt Limited | -4.63 Billion INR | 785.307% |
| Vaishali Pharma Limited | 7.18 Million INR | -441264.585% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -1362.859% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -14025.317% |
| Jubilant Pharmova Limited | 771 Million INR | -4015.396% |
| FDC Limited | 3.05 Billion INR | -939.557% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 43.018% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -21630.587% |
| Eris Lifesciences Limited | 3.91 Billion INR | -709.466% |
| Venus Remedies Limited | 284.9 Million INR | -11036.823% |
| ZIM Laboratories Limited | 172.46 Million INR | -18297.869% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -4105.166% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | -21781.043% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | -594.167% |
| Shilpa Medicare Limited | 318.74 Million INR | -9854.666% |
| Albert David Limited | 754.2 Million INR | -4107.062% |
| Ajanta Pharma Limited | 8.16 Billion INR | -288.763% |
| Hester Biosciences Limited | 188.89 Million INR | -16697.978% |
| Suven Pharmaceuticals Limited | 3 Billion INR | -956.669% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 659.222% |
| Gufic Biosciences Limited | 861.35 Million INR | -3583.692% |
| Windlas Biotech Limited | 581.87 Million INR | -5353.057% |
| Procter & Gamble Health Limited | 2 Billion INR | -1478.749% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | -67645.421% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 35076.576% |
| Granules India Limited | 4.05 Billion INR | -682.85% |
| Aarti Drugs Limited | 1.71 Billion INR | -1751.011% |
| Bal Pharma Limited | 73.92 Million INR | -42823.216% |
| Alkem Laboratories Limited | 17.95 Billion INR | -76.691% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 66.867% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | -3300.647% |
| Medicamen Biotech Limited | 109.31 Million INR | -28927.262% |
| Unichem Laboratories Limited | -704.74 Million INR | 4602.308% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | -43081.998% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -447301.297% |
| Valiant Laboratories Limited | 3.19 Million INR | -992694.118% |
| Orchid Pharma Limited | 921.66 Million INR | -3342.65% |
| Medico Remedies Limited | 82.9 Million INR | -38170.513% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | -653.743% |
| Ipca Laboratories Limited | 5.47 Billion INR | -479.697% |
| Brooks Laboratories Limited | -195.91 Million INR | 16295.315% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -12434.348% |
| Piramal Enterprises Limited | -16.83 Billion INR | 288.471% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | -91.561% |
| NATCO Pharma Limited | 13.88 Billion INR | -128.551% |
| Suven Life Sciences Limited | -1.05 Billion INR | 3119.682% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 16183.261% |
| Strides Pharma Science Limited | -706.14 Million INR | 4593.401% |
| Indoco Remedies Limited | 984.6 Million INR | -3122.595% |
| Alpa Laboratories Limited | 167.76 Million INR | -18813.182% |
| Lasa Supergenerics Limited | -217.3 Million INR | 14701.392% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 919.436% |